Bourse
Stock filings

RAPP insider trades & Congress trades

Rapport Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.

31insider buys + sells
0Congress trades
11 / 20insider buys / sells, 90 days
Oct 28, 2026latest buying cluster

Bourse has recorded 31 open-market insider transactions in Rapport Therapeutics, Inc. (RAPP) (11 purchases with code P and 20 sales with code S), the most recent on October 28, 2026.

In the last 90 days: 11 purchases by 7 insiders ($22.0M) and 20 sales by 3 ($6.92M).

The most recent insider buying cluster (three or more different insiders buying within 14 days) ran from October 22, 2026 to October 28, 2026, with 6 insiders.

Insider transactions

SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.

DateInsiderRoleTypeSharesPriceValueAfter 1M
Oct 28, 2026Healy James–Buy952,380$21.00$20.0M–
Oct 28, 2026Healy James–Buy6,395$21.00$134K–
Oct 28, 2026Healy James–Buy3,772$21.00$79K–
Oct 28, 2026Healy James–Buy6,933$21.00$146K–
Oct 23, 2026Sanchez RamiroChief Medical OfficerBuy3,600$27.35$98K–
Oct 22, 2026Paul Steven M–Buy35,714$27.28$974K–
Oct 22, 2026Maraganore John–Buy8,239$26.38$217K–
Oct 22, 2026Maraganore John–Buy1,172$26.92$32K–
Oct 22, 2026Silva Paul M–Buy3,680$27.08$100K–
Oct 22, 2026Young Wendy B.–Buy3,789$26.39$100K–
Oct 21, 2026Ignelzi Troy A.Chief Financial OfficerBuy5,500$26.10$144K–
Oct 21, 2026Ceesay AbrahamChief Executive OfficerSell2,210$29.16$64K–
Oct 7, 2026Ceesay AbrahamChief Executive OfficerSell1,147$30.66$35K–
Oct 6, 2026Ceesay AbrahamChief Executive OfficerSell3,375$32.03$108K–
Sep 30, 2026Gault CherylChief Operating OfficerSell7,925$33.04$262K−0.2%
Sep 30, 2026Gault CherylChief Operating OfficerSell2,075$33.76$70K−0.2%
Sep 23, 2026Ceesay AbrahamChief Executive OfficerSell1,952$39.05$76K−0.2%
Sep 23, 2026Ceesay AbrahamChief Executive OfficerSell215$39.86$9K−0.2%
Sep 23, 2026Ceesay AbrahamChief Executive OfficerSell43$41.05$2K−0.2%
Sep 8, 2026Ceesay AbrahamChief Executive OfficerSell7,141$45.56$325K−0.3%
Sep 8, 2026Ceesay AbrahamChief Executive OfficerSell1,069$46.01$49K−0.3%
Aug 25, 2026Yeleswaram KrishnaswamyChief Development OfficerSell20,799$50.31$1.05M−0.4%
Aug 25, 2026Yeleswaram KrishnaswamyChief Development OfficerSell16,201$51.06$827K−0.4%
Aug 25, 2026Ceesay AbrahamChief Executive OfficerSell18,921$49.57$938K−0.4%
Aug 24, 2026Yeleswaram KrishnaswamyChief Development OfficerSell13,160$50.00$658K−0.4%
Aug 19, 2026Yeleswaram KrishnaswamyChief Development OfficerSell404$49.90$20K−0.2%
Aug 11, 2026Ceesay AbrahamChief Executive OfficerSell3,664$46.90$172K−0.1%
Aug 11, 2026Ceesay AbrahamChief Executive OfficerSell19,500$48.04$937K−0.1%
Aug 11, 2026Ceesay AbrahamChief Executive OfficerSell5,794$48.62$282K−0.1%
Aug 10, 2026Ceesay AbrahamChief Executive OfficerSell14,171$45.97$651K−0.1%

Showing the 30 most recent of 31 transactions.

Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.

New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.

See these filings as they land

Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.

Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.